Summary
144 depressed in-patients were rated by means of the Comprehensive Psychopathological Rating Scale (CPRS) and platelet monoamine oxidase (MAO) was determined. 49 per cent of the patients were found to have pain as a symptom, and 21 per cent were found to have more severe pain. The patients with more severe pain were found to have lower platelet MAO activity than the patients without pain or with slight pain. As platelet MAO activity may reflect the turn-over in the serotinergic systems in CNS it is hypothesized that patients with depressive disorders with pain as a symptom may have more pronounced disturbances in the serotinergic systems than patients without pain as a symptom.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åberg-Wistedt, A.: A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings. Acta Psychiatr. Scand.66, 50–65 (1982).
Åberg-Wistedt, A., Ross, S. B., Jostell, K.-G., Sjöquist, B.: A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings. Acta Psychiatr. Scand.66, 66–82 (1982).
Akil, H., Myer, D. J.: Antagonism of stimulation-produced analgesia by p-CPA, a serotonin synthesis inhibitor. Brain Res.44, 692–697 (1972).
Akil, H., Liebeskind, J. C.: Monoaminergic mechanism of stimulation-produced analgesia. Brain Res.94, 279–296 (1975).
Almay, B. G. L., Johansson, F., von Knorring, L., Terenius, L., Wahlström, A.: Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain5, 153–162 (1978).
Åsberg, M., Thoren, P., Träskman, L., Bertilsson, L., Ringberger, V. A.: Serotonin depression: A biochemical subgroup within the affective disorders. Science191, 478–480 (1976).
Åsberg M., Träskman, L., Thoren, P.: 5-HIAA in cerebrospinal fluid: A biochemical suicide predictor. Arch. Gen. Psychiat.33, 1193–1197 (1976).
Åsberg, M., Perris, C., Schalling, D., Sedvall, G.: The CPRS-development and application of a psychiatric rating scale. Acta Psychiat. Scand., Suppl. 271 (1978).
Åsberg M., Bertilsson, L., Mårtensson, B., Scalia-Tomba, G. P., Thoren, P., Träskman-Bendz, L.: CSF monoamine metabolism in melancholia. Manuscript, 1983.
Basbaum, A. I., Fields, H. L.: Brainstem control of spinal brain transmission neurons. Amer. Rev. Physiol.40, 217–248 (1978).
Blumer, D., Heilbrown, M.: Chronic pain as a variant of depressive disease. J. Nerv. Ment. Dis.170, 381–416 (1982).
Buchsbaum, M. S., Haier, R. J., Murphy, D. h.: Suicide attempts, platelet monoamine oxidase and the average evoked response. Acta psychiat. Scand.56, 69–79 (1977).
Coppen, A.: The biochemistry of affective disorders. Brit. J. Psychiat.113, 1237–1264 (1967).
Eckert, B., Gottfries, C. G., von Knorring L., Wiberg Å., Winblad, B.: Brain and platelet monoamine oxidase activity in mental disorders. I. Schizophrenics and cycloid psychotics. Progr. Neuro-Psychopharmacol.4, 57–68 (1980).
d'Elia, G., von Knorring L., Perris, C.: Non-psychotic depressive disorders, a ten year follow-up. Acta psychiat. Scand., Suppl.255, 173–186 (1974).
Fowler, J. C., Oreland, L.: Human platelet monoamine oxidase — some biochemical findings. In: Monoamine Oxidase, Basic and Clinical Frontiers (Kamijo, K., Usdin, E., Nagatsu, T., eds.), pp. 28–39. Amsterdam: Excerpta Medica. 1982.
Gottfries, C. G., von Knorring, L., Oreland, L.: Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behaviour. Prog. Neuro-Psychopharmacol.4, 185–192 (1980).
Johansson, F., von Knorring, L.: A double-blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain7, 69–78 (1979).
von Knorring L.: The experience of pain in patients with depressive disorder. A clinical and experimental study. Neuropsychobiology1, 155–165 (1975).
von Knorring L., Oreland, L., Perris, C., Eisemann, M., Perris, H.: Platelet MAO activity in affective disorders. Relationship to suicidal behaviour. J. Nerv. Ment. Dis. (submitted, 1984).
von Knorring L., Perris, C., Eisemann, M., Eriksson, U., Perris, H.: Pain as a symptom in depressive disorders. I. Relationship to diagnostic subgroup and depressive symptomatology. Pain15, 19–26 (1983).
Merskey, H., Spear, F. G.: Pain. Psychological and Psychiatric Aspects. London: Balliére, Tindall and Cassell. 1967.
Messing R. B., Lytle, L. D.: Serotonin-containing neurons: their possible role in pain and analgesia. Pain4, 1–22 (1977).
Mohamed, S. N., Weisz, G. M., Waring, E. M.: The relationship of chronic pain to depression, marital adjustment and family dynamics. Pain5, 285–292 (1978).
Murphy, D. C., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L., Wyatt, R. J.: Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time. Biochem. Med.16, 254–265 (1976).
Nies, A., Robinson, D. S., David, J. M., Ravaris, C. L.: Changes in monoamine oxidase with aging. In: Psychopharmacology and Aging (Eisdorfer, C., Fann, W. E., eds., pp. 41–54. New York-London: Plenum Press. 1974.
Oreland, L., Wiberg, Å., Åsberg, M., Träskman, L., Sjöstrand, L., Thoren, P., Bertilsson, L., Tybring, G.: Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res.4, 21–29 (1981).
Oreland, L., Shaskan, E. G.: Some rationale behind the use of monoamine oxidase activity as a biological marker. Trends Pharmacol. Sci.4, 339–341 (1983).
Perris, C.: A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiat. Scand., Suppl.194 (1966).
Perris, C., Eriksson, U., Jacobsson, L., Lindström, H., Perris, H.: Interprofessional communicability and reliability of the comprehensive psychopathological rating scale (CPRS) as assessed by video-taped interviews. Acta Psychiat. Scand.60, 144–148 (1977).
Perris, C., Perris, H., Eriksson, U., von Knorring, L.: The genetics of depression. A family study of unipolar and neurotic-reactive depressed patients. Arch. Psychiatr. Nervenkr.232, 137–155 (1982).
van Praag, H. M., Korf, J., Schut, D.: Cerebral monoamine and depression. Arch. Gen. Psychiat.28, 827–831 (1973).
Sicuteri, F.: Prophylactic and therapeutic properties of 1-methyllysergic acid butanolamide in migraine. Int. Arch. Allergy15, 300–307 (1959).
Sicuteri, F., Anselmi, B., Del Bianco, P. L.: 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine. Psychopharmacologia29, 347–356 (1975).
Sternbach, R. A.: Pain Patients, Traits and Treatment. London: Academic Press. 1974.
Sternbach, R. A.: The Psychology of Pain. New York: Raven Press. 1980.
Träskman-Bendz, L.: Depression and suicidal behaviour-a biochemical and pharmacological study. Academic Diss., Stockholm, 1980.
Ward, N. G., Bloom, V. L., Friedel, R. O.: The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain7, 331–341 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Knorring, L., Perris, C., Oreland, L. et al. Pain as a symptom in depressive disorders and its relationship to platelet monoamine oxidase activity. J. Neural Transmission 60, 1–9 (1984). https://doi.org/10.1007/BF01254760
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01254760